RNA polymerase (pol) III transcription is a major determinant of biosynthetic capacity, providing essential products such as tRNA and 5S rRNA. It is controlled directly by the tumour suppressors RB and p53. High-risk types of human papillomavirus (HPV), such as HPV16, express the oncoproteins E6 and E7 that can inactivate p53 and RB, respectively. Accordingly, both E6 and E7 stimulate pol III transcription in cultured cells. HPV16-positive cervical biopsies express elevated levels of tRNA and 5S rRNA when compared to biopsies that test negative for HPV or are infected with the lower risk HPV11. Integration of viral DNA into the host cell genome stimulates expression of E6 and E7 and correlates with induction of tRNA and 5S rRNA. Expression of mRNA encoding the pol III-specific transcription factor Brf1 also correlates with the presence of integrated HPV16. Brf1 levels are limiting for tRNA and 5S rRNA synthesis in cervical cells. Furthermore, pol III-transcribed genes that do not use Brf1 are not induced in HPV16-positive biopsies. Three complementary mechanisms may therefore allow high-risk HPV to stimulate production of tRNA and 5S rRNA: E6-mediated removal of p53; E7-mediated neutralization of RB; and induction of Brf1. The resultant increase in biosynthetic capacity may contribute to deregulated cell growth.
Introduction
Carcinoma of the cervix is the second most common gynaecological malignancy, accounting for B12% of cancers in women worldwide and causing B250 000 deaths per annum (zur Hausen, 2002; Baldwin et al., 2003) . Its aetiological association with human papillomavirus (HPV) is well established (zur Hausen, 2000; Baldwin et al., 2003) . Furthermore, B25% of oropharyngeal cancers contain DNA from the same types of HPV (zur Hausen, 2000) . The most prevalent high-risk type is HPV16, which is associated with intraepithelial neoplasias and progression to invasive cervical cancers, whereas low-risk types, such as HPV6 and HPV11, are most often implicated in benign proliferative genital warts with a low propensity for carcinogenic progression (zur Hausen, 2000 (zur Hausen, , 2002 .
Unlike the HPV-associated benign lesions, where the viral genome is maintained episomally, the majority of HPV-associated cancers contain viral DNA integrated into the genome of the host cells (Schwarz et al., 1985; Yee et al., 1985) . While most of the open reading frames of the integrated viral DNA are lost or interrupted, the HPV oncoproteins E6 and E7 continue to be expressed (Schwarz et al., 1985) . Furthermore, expression of both proteins is upregulated upon integration, because the gene encoding the viral transcriptional repressor E2 is generally lost and the mRNA encoding E6 and E7 is stabilized (Jeon et al., 1995a, b) . E6 and E7 proteins encoded by HPV16 interact with p53 and the retinoblastoma protein RB to inactivate these tumour suppressors Munger et al., 1989; Werness et al., 1990) . Inactivation of p53 and RB, two cardinal regulators of the cell cycle, leads to uncontrolled cell growth and proliferation.
RNA polymerase (pol) III synthesizes many essential short untranslated RNAs, including tRNA and 5S rRNA (White, 2002) . Pol III products are generally found to be overexpressed in transformed and tumour cells (e.g. Scott et al., 1983; Chen et al., 1997a, b; FeltonEdkins and White, 2002) . This probably reflects the fact that abundant supplies of tRNA and rRNA are needed for sustained cell growth (White, 2004a, b) . Although many studies have tested how transforming agents stimulate pol III output in cultured cells, this has yet to be addressed in human tumours. The sole exception to date is a study that examined how tRNA and 5S rRNA synthesis is deregulated in ovarian carcinomas (Winter et al., 2000) . These cancers were found to consistently express abnormally high levels of the pol III-specific transcription factor TFIIIC2 (Winter et al., 2000) . This same factor is also overexpressed in fibroblasts transformed by polyomavirus or SV40 (Larminie et al., 1999; Felton-Edkins and White, 2002) . However, it remains to be determined if elevated TFIIIC2 levels are a widespread feature of different tumour types.
The principle function of TFIIIC2 is to recruit a second factor called TFIIIB, which is responsible for bringing pol III to the promoter (Geiduschek and Kassavetis, 2001; Schramm and Hernandez, 2002; White, 2002) . In untransformed cells, TFIIIB is bound and repressed by both RB and p53 (Felton-Edkins et al., 2003) . Inactivation of either of these tumour suppressors can cause elevated rates of pol III transcription in vivo (Felton-Edkins et al., 2003) . For example, neutralizing RB with the E7 oncoprotein of HPV16 can stimulate expression of a pol III reporter in transfected fibroblasts, but this response is abolished by mutations that prevent the RB/E7 interaction (Larminie et al., 1999; Sutcliffe et al., 1999) . Similarly, HPV16 E6 oncoprotein can relieve repression of a pol III reporter by p53 transfected into SAOS2 cells (Stein et al., 2002) . Although these observations suggest that HPV16 infection will increase pol III output, this remains to be tested in cervical cells, the principle context in which this virus impacts on human health.
Results

Integration of HPV16 raises expression of pol III transcripts
Following infection of the anogenital mucosa, the HPV genome is initially maintained as an episome, but integration of viral DNA into host chromosomes often accompanies malignant progression (Boshart et al., 1984; Schwarz et al., 1985; Alazawi et al., 2002) . This integration results in elevated expression of both E6 and E7 (Jeon et al., 1995a, b; Alazawi et al., 2002) . W12 is a line of HPV16-infected human cervical keratinocytes that was generated from a squamous epithelial lesion; matched subclones were compared, which carry either episomal or integrated copies of the viral DNA. We used RT-PCR to test whether integration of HPV16 is associated with changes in the expression of pol III transcripts in the W12 model system (Figure 1) . A range of pol III products was found to be overexpressed in two subclones carrying integrated HPV16 (lanes 2 and 3), when compared with matched cells in which the viral genome remains episomal (lane 1). Thus, elevation was observed in the integrated lines W12G and W12GPXY for tRNA Arg , tRNA Leu , the unique selenocysteine tRNA (tRNA Sec ), 5S rRNA, the MRP RNA, which is required both for mitochondrial replication and the processing of large rRNA (Clayton, 2001 ) and the 7SK RNA, which regulates the pol II transcription elongation factor P-TEFb (Nguyen et al., 2001 , Yang et al., 2001 .
Although every pol III transcript tested was induced to some extent in the cells with viral integration, the effect shows specificity, as it is not seen with the pol II-derived mRNA encoding acidic ribosomal phosphoprotein P0 (ARPP P0). For tRNA Leu and tRNA Arg , which contain introns, our RT-PCR primers detect the short-lived primary transcript that is considered to provide a strong indicator of ongoing transcription, because of its rapid processing into mature tRNA (Winter et al., 2000) . In all the other cases, steady-state RNA levels were measured. These data suggest a specific elevation of pol IIIdependent gene expression when HPV16 integrates into the genome of cervical cells, an event often associated with malignant progression.
Cervical biopsies infected with HPV16 express elevated levels of tRNA and 5S rRNA RT-PCR analysis was also used to examine levels of pol III transcripts in cervical biopsy samples that had been tested for HPV status. Initially, we examined seven biopsies that tested positive for HPV16 alongside three in which HPV was not detected. Expression of 5S rRNA, tRNA Arg and tRNA Sec was significantly elevated in each of the HPV16-containing samples when compared with the HPV-negative biopsies (Figure 2a ). Primary transcripts from the tRNA Leu genes were also expressed most strongly in the HPV16-positive samples, although there was overlap between levels in the most active HPV-negative biopsies (samples 8 and 9) and the least active HPV16-positive biopsies (samples 1 and 2). These variations do not reflect differential RNA extraction or integrity, as they were not displayed by the pol II-derived ARPP P0 mRNA control. Unlike the other biopsies in Figure 2a , the HPV genome has remained episomal in sample 1 and has failed to undergo integration. The lower expression of tRNA and 5S rRNA in this biopsy is therefore consistent with our results from the W12 model, which suggest that pol III activity may be enhanced by HPV16 integration.
The HPV16-positive samples were also compared with three biopsies containing HPV33 or HPV11. HPV33 is less commonly associated with tumours than HPV16, although it is still considered a high-risk type, whereas HPV11 is classified as low-risk (zur Hausen, 2002) . For 5S rRNA and each of the tRNAs examined, expression was significantly higher in the biopsies with HPV16 when compared with the other specimens ( Figure 2b ). This may reflect differences between the viral types and/or the fact that the virus had failed to integrate in the two HPV33-positive samples.
Quite different patterns of expression were observed for 7SK and MRP RNA. Whereas the former remained relatively constant, the latter varied markedly between samples, but not in a manner that correlated with HPV status or tRNA expression (Figure 2a and b). However, both these transcripts showed a dramatic elevation in one HPV11-positive tumour (biopsy 14).
Variable expression in cervical cells of mRNAs encoding TFIIIC2 and TFIIIB
The distinct response of 7SK and MRP might reflect their very different promoter arrangements from those of 5S rRNA and tRNA genes. Thus, sequences upstream of the initiation site are necessary and sufficient for 7SK and MRP gene transcription, in contrast to the internal promoters found in most pol III templates (Murphy et al., 1987; Yuan and Reddy, 1991) . This results in distinct factor requirements (reviewed by Geiduschek and Kassavetis, 2001; Schramm and Hernandez, 2002) . For example, TFIIIC2 is necessary for expression of tRNA and 5S rRNA, but is not used by genes such as 7SK that lack internal promoters (Geiduschek and Kassavetis, 2001; Schramm and Hernandez, 2002; White, 2002) . We therefore examined if TFIIIC2 expression might respond to HPV. RT-PCR was used to compare, in 10 cervical biopsies, the relative levels of mRNAs encoding the five subunits of TFIIIC2 ( Figure 3 ). Expression of these mRNAs was found to vary substantially between different samples. The reason for this variability is currently unclear, but it does not correlate with HPV status. Accordingly, we found no evidence that TFIIIC2 genes are induced in response to HPV16 integration in W12 cells (data not shown). Furthermore, there is no correlation between the relative levels of these mRNAs and pol III transcript expression. These data suggest that TFIIIC2 may not be limiting in this cell type and that HPV16 does not induce expression of TFIIIC2 genes. Figure 2 The presence of integrated HPV16 DNA in human biopsies correlates with elevated expression of tRNA and 5S rRNA. cDNAs generated by reverse transcription of 2 mg of RNA from the indicated biopsy samples were PCR amplified using specific primers for the transcripts indicated RT-PCR was also used to assay relative levels of the mRNAs encoding TFIIIB. This is a complex composed of three subunits, TBP, Brf1 and Bdp1 (Geiduschek and Kassavetis, 2001; Schramm and Hernandez, 2002) . Of these, Bdp1 is strongly induced in fibroblasts by SV40 and polyomavirus, whereas TBP and Brf1 do not respond to these viruses (Felton-Edkins and White, 2002) . In contrast, we found no evidence that HPV16 induces Bdp1 expression in cervical epithelium ( Figure  4a and b) . However, substantial variations in Bdp1 mRNA were detected between biopsy samples, including dramatic elevation in tumour biopsy 14 that is infected with HPV11 ( Figure 4b ). It is striking that the carcinoma with especially high Bdp1 mRNA is also the tumour that overexpresses 7SK and MRP RNA (Figure 2a ). Although this suggests that very high levels of Bdp1 might activate 7SK and MRP gene transcription, there is no clear correlation between Bdp1, 7SK and MRP RNAs in the other biopsy samples.
Relative levels of TBP mRNA also varied markedly between individual biopsy samples, but again there was no obvious correlation with either HPV status or expression of particular pol III products (Figure 4a and b). However, a correlation was found between both these parameters and the relative levels of mRNA encoding the TFIIIB-specific subunit Brf1. Thus, Brf1 expression was maximal in biopsies that displayed the highest output of tRNA and 5S rRNA. In all but one case, this correlated with the presence of HPV16; the exception is sample 1, which showed little or no elevation of Brf1 mRNA and also had the lowest tRNA levels of the HPV16-positive biopsies. In contrast to the other biopsies, the viral genome was found in sample 1 Figure 3 The presence of integrated HPV16 DNA in human biopsies does not correlate with any change in expression of mRNAs encoding TFIIIC2. cDNAs generated by reverse transcription of 2 mg of RNA from the indicated biopsy samples were PCR amplified using specific primers for the transcripts indicated Figure 4 RT-PCR analysis of mRNAs encoding TFIIIB subunits in human biopsies and W12 cells. (a, b) cDNAs generated by reverse transcription of 2 mg of RNA from the indicated biopsy samples were PCR amplified using specific primers for the transcripts indicated. (c) cDNAs generated by reverse transcription of 2 mg of RNA from W12 cells with episomal (lane 1) or integrated HPV16 DNA (lanes 2 and 3) were PCR amplified using specific primers for the transcripts indicated Deregulation of RNA polymerase III transcription NL Daly et al to be episomal rather than integrated into the host cell DNA. This is consistent with our results from the W12 model, which suggest that pol III activity is enhanced by HPV16 integration. In addition, it raised the possibility that viral integration may also stimulate Brf1 expression. To test this, we examined whether the W12 cells with integrated HPV16 contain higher levels of Brf1 mRNA than W12 cells in which the viral genome remains episomal; this was indeed the case (Figure 4c ).
Inactivation of RB or p53 does not raise expression of Brf1 mRNA Viral integration has been shown to stimulate expression of E6 and E7. Accordingly, analysis of E7 mRNA levels using HPV16-specific primers revealed the lowest expression in sample 1, in which the virus has remained episomal ( Figure 5 ). The level of E7 mRNA in these samples correlates with that of Brf1, with samples 3-6 showing highest expression of both. This raised the possibility that Brf1 may be induced by E7, perhaps through inactivation of RB or its relatives p107 and p130. We therefore investigated whether Brf1 expression responds to the loss of the RB family. To this end, transcript levels were compared from matched embryonic fibroblasts of wild-type and RB-knockout mice. Although tRNA gene expression is clearly elevated in the Rb À/À cells, as demonstrated previously (White et al., 1996; Scott et al., 2001) , no increase was seen in Brf1 mRNA ( Figure 6, lanes 1 and 2) . Similarly, triple knockout (TKO) fibroblasts from Rb
mice show elevated tRNA, but normal levels of Brf1 mRNA ( Figure 6 , lanes 3 and 4). This suggests that the elevated Brf1 expression in HPV16-positive tumours is unlikely to result from inactivation of RB or its relatives. We adopted a similar approach to test if the effect is caused by E6-mediated ablation of p53, by comparing expression in matched embryonic fibroblasts from wild-type and p53-knockout mice. Again, Brf1 mRNA levels remained unchanged, although tRNA expression is elevated in the knockouts (Figure 6 , lanes 5 and 6), as shown previously by nuclear run-on analysis (Cairns and White, 1998) . Synthesis of tRNA increases in both sets of knockouts because RB and p53 bind to TFIIIB to repress pol III transcription directly (Cairns and White, 1998; Larminie et al., 1997) . However, Brf1 expression seems not to change under these conditions. Brf1 mRNA levels are also unperturbed in the RB À/À p53 À/À osteosarcoma line SAOS2, when compared with U20S osteosarcoma cells that contain wild-type RB and p53 (Figure 6 , lanes 7 and 8). It therefore seems unlikely that E6-mediated ablation of p53 or E7-mediated neutralization of RB are responsible for the elevated levels of Brf1 mRNA seen in HPV16-positive cancers.
Brf1 is a limiting factor for pol III transcription in cervical cells
The correlation observed in biopsy samples between levels of tRNA, 5S rRNA and Brf1 mRNA suggests that Brf1 availability may limit the rate of transcription of many pol III templates in cervical epithelium. To test this, we investigated whether raising the level of Brf1 can stimulate transcription of tRNA and 5S rRNA genes in cervical cells. Previous work showed that pol III transcription increases markedly at the G1/S phase transition due to a marked increase in TFIIIB activity as it dissociates from RB and p130 (White et al., 1995b; Scott et al., 2001) . We therefore examined the response to Brf1 in both G1 and S phases. HeLa cells were transfected with an expression vector encoding Brf1 and then were synchronized using either thymidine or nocodozole blocks to arrest cell cycle progression; after release from these synchronizing blocks, the cells were harvested in either early G1 or S phase. As previously demonstrated with nuclear run-on assays (White et al., 1995b) , pol III transcription is substantially less active before the G1/S transition (Figure 7 ). Transfection of Brf1 had only a marginal effect on the ability of S phase cells to transcribe a tRNA gene, but it strongly stimulated expression in G1 phase cells (Figure 7a ). However, 5S rRNA gene transcription was increased markedly by Brf1 in both G1 and S phase cells (Figure 7b ). In contrast, pol III transcription of the 7SK gene showed no response under identical conditions (Figure 7c ), in keeping with its distinct promoter Figure 5 Comparison of E7 mRNA expression in cervical biopsy samples. cDNAs generated by reverse transcription of 2 mg of RNA from the indicated biopsy samples were PCR amplified using specific primers for mRNA encoding HPV16 E7 (upper band) and ARPP P0 (lower band) Figure 6 Expression of Brf1 mRNA does not increase in RB-or p53-knockout fibroblasts. cDNAs were generated by reverse transcription of 2 mg of RNA from embryonic fibroblasts of wildtype (lanes 1, 3 and 5), RB-knockout (lane 2), RB, p107, p130 triple-knockout (lane 4) or p53-knockout (lane 6) mice, and from U2OS (lane 7) and SAOS2 (lane 8) osteosarcoma cell lines. These cDNAs were PCR amplified using specific primers for tRNA Leu , Brf1 mRNA and ARPP P0 mRNA, as indicated organization and factor requirements (Schramm and Hernandez, 2002) . These data provide clear evidence that an increase in Brf1 levels can selectively stimulate synthesis of tRNA and 5S rRNA in cervical cells. They therefore offer an explanation for the observed correlation in cervical biopsies between levels of these pol III products and the Brf1 mRNA.
Discussion
Expression of tRNA and 5S rRNA is markedly elevated in a set of HPV16-positive cervical biopsies, when compared with similar biopsies that carry low-risk HPV11 or test negative for the common HPV types. For tRNA Leu and tRNA Arg , we are able to assay the short-lived primary transcript, levels of which provide a reliable indicator of the rate of ongoing transcription (Winter et al., 2000) . The same set of samples overexpresses mRNA encoding Brf1, a pol III-specific subunit of TFIIIB. Furthermore, raising the level of Brf1 in cervical cells can specifically increase transcription of tRNA and 5S rRNA genes. Thus, induction of Brf1 could be responsible for the observed abundance of tRNA and 5S rRNA in cervix infected with HPV16. However, an alternative explanation is provided by the fact that the E6 and E7 products of HPV16 can both derepress TFIIIB, by neutralizing p53 and RB, respectively (Larminie et al., 1999; Sutcliffe et al., 1999; Stein et al., 2002) . Viral integration stimulates production of these oncoproteins and also correlates in cultured W12 cells with increased levels of pol III transcripts and Brf1 mRNA. Induction of these products is much less apparent in a biopsy in which HPV16 has remained unintegrated and in two biopsies carrying only episomal copies of high-risk HPV33. These observations support the possibility that viral integration impacts on the pol III system, but variation in viral copy number and/or site of integration may also contribute to the differences in expression between individual samples. We postulate that HPV16 integration may raise TFIIIB activity through three distinct mechanisms -release from RB, release from p53 and overexpression of Brf1. The relative impact of these three strategies might depend on multiple parameters, such as cell cycle status or conditions like hypoxia that can activate p53. It is likely that other high-risk viral types, such as HPV18, might give similar effects, but the biopsies we collected did not provide samples that allow this issue to be addressed. No significant induction was observed with two biopsies that are positive for HPV33, which is considered highrisk, but this may reflect the fact that the virus had remained unintegrated in both cases.
7SK and MRP RNAs respond very differently from tRNA and 5S rRNA. It is reasonable to assume that this reflects the different factor requirements of genes such as 7SK and MRP that utilize upstream promoter arrangements. Thus, unlike tRNA and 5S rRNA genes, which have internal promoters, such genes do not utilize TFIIIC2 or Brf1 (Schramm and Hernandez, 2002) . Indeed, 7SK transcription does not respond to an increase in Brf1 concentration (Figure 7 ). These genes do require TBP and Bdp1 (Schramm and Hernandez, 2002) and it is striking that 7SK and MRP are both expressed at high levels in a tumour that selectively overproduces Bdp1. However, neither TBP nor Bdp1 mRNA expression correlates with 7SK or MRP RNA in the other biopsy samples. Availability of some other factor (perhaps PTF/SNAPc) may therefore limit transcription from external pol III promoters in cervical epithelium.
In interpreting these results, we are making an assumption that transcription factor levels in these tissue samples reflect the expression of their corresponding mRNAs. Thus, we assume that tumours with high Leu gene using 10 mg of extract made from HeLa cells transfected with empty vector (10 mg lanes 1 and 4; 5 mg lanes 2 and 5) and pcDNA3-HA.BRF (5 mg lanes 2 and 5; 10 mg lanes 3 and 6). After transfection, the cells were synchronized in S (lanes 1-3) or G1 (lanes 4-6) phases prior to harvesting. (b) As above, except that a 5S rRNA gene was used as transcription template. (c) Transcription of a 7SK gene using 10 mg of extract made from HeLa cells transfected with empty vector (lanes 1 and 3) or 10 mg of pcDNA3HA.BRF (lanes 2 and 4). After transfection, the cells were synchronized in G1 (lanes 1 and 2) or S (lanes 3 and 4) phases prior to harvesting Brf1 mRNA are likely to have elevated Brf1 protein content. We acknowledge that this need not be the case, as post-transcriptional controls might have a significant influence. However, the very limited amounts of biopsy material available have precluded analysis at the protein level.
Previous studies have shown that all five mRNAs encoding the subunits of TFIIIC2 are induced when fibroblasts are transformed by SV40 or polyomavirus (Larminie et al., 1999; Felton-Edkins and White, 2002) . Furthermore, adenoviral infection can selectively increase the level of TFIIIC110 (Sinn et al., 1995) . This led us to wonder if TFIIIC2 might also be induced when cells are infected and transformed by HPV, but we found no evidence that this is the case. Evidently, TFIIIC2 expression does not respond to all types of DNA tumour virus.
The X oncoprotein of hepatitis B virus can increase TBP expression in S2 and Rat1A cells and thereby stimulate pol III transcription (Wang et al., 1997) . The levels of TBP mRNA fluctuated dramatically in the biopsies analysed here, but did not correlate with any of the pol III transcripts we examined. TBP may therefore not be limiting for synthesis of these products in cervical cells, a conclusion supported by previous in vitro analysis (White et al., 1995a, b) . Bdp1 mRNA levels also vary markedly between biopsies and again this shows little correlation with expression of pol III templates, suggesting that Bdp1 may be in relative excess in the cervix. However, the highly elevated Bdp1 mRNA in biopsy 14 coincides with induction of 7SK and MRP, suggesting that transcription of these genes might be activated by very high levels of Bdp1, even if it is not normally limiting. It is unclear what caused the dramatic overexpression of Bdp1 mRNA in the tumour in biopsy 14, but we could find no evidence for gene amplification. Induction of Bdp1 is also found in fibroblasts transformed by SV40 or polyomavirus (Felton-Edkins and White, 2002) .
Our data provide the first evidence that a virus may induce Brf1 expression. The mechanism remains to be determined, but appears to be sensitive to viral integration. An obvious possibility is that the Brf1 gene is itself regulated by the RB and/or p53 pathways that respond to the induction of E6 and E7 that accompanies HPV integration. Arguing against this scenario is the fact that Brf1 expression is unchanged in embryonic fibroblasts from mice that are knockout for p53, RB, or the entire RB family. Brf1 mRNA levels also appear normal in SAOS2 cells, which lack both RB and p53. Although the situation may be different in cervical epithelium in situ, the available evidence argues that the observed induction of Brf1 is independent of changes to RB or p53. This does not exclude an involvement of E6 and/or E7, since both have been shown to interact with multiple targets in addition to p53 and RB (zur Hausen, 2000; Munger et al., 2001) .
The benefit for HPV16 of targeting Brf1 can be readily explained by the fact that it is limiting for tRNA and 5S rRNA synthesis in cervical cells, the natural site of infection. Clearly, the most effective way to obtain a transcriptional response is to regulate a limiting factor. Since E6 and E7 can increase pol III output by derepressing TFIIIB, it is striking that HPV16 seems to have evolved an additional mechanism for activating this transcription system. This suggests that a high rate of tRNA and 5S rRNA synthesis is advantageous to the virus, perhaps by raising translational capacity to facilitate production of viral proteins. It is also striking that this mechanism is associated with the highly oncogenic HPV16, but is not apparent with HPV11 that is less likely to promote malignant progression. This observation is consistent with a link between cell transformation and abnormally elevated pol III activity.
Materials and methods
Cells and tissue
Cervical biopsy material was obtained from the Department of Obstetrics and Gynaecology of the University Hospital of Heraklion, Crete. It came from women aged 33-81 undergoing hysterectomy for cervical carcinomas, FIGO stages III and IV. The University of Crete ethics committee approved this study and all patients gave written informed consent. Tissue was removed surgically and snap-frozen on dry ice. HPV status was determined by PCR using general primers GP5-GP6 (Snijders et al., 1990) as well as primers specific for HPV11, HPV16, HPV18 and HPV33 (Arends et al., 1991) . PCR reaction conditions have been described (Koffa et al., 1994) .
Biopsies 1-7 all tested positive for HPV16; the viral genome was episomal in biopsy 1 and integrated in biopsies 2-7. No HPV was detected in biopsies 8-10, although we cannot exclude the possibility that rare HPV types might be present. Biopsies 11 and 12 both carried episomal HPV33, whereas integrated HPV11 was found in biopsies 13 and 14.
HeLa is a cervical carcinoma cell line containing integrated copies of the HPV18 genome (Gey et al., 1952) . W12 is an HPV16 positive cervical epithelial cell line established from a low-grade lesion (Stanley et al., 1989) . The virus is entirely episomal in subclone W12E, but has integrated in subclones W12G and W12GPXY (Aasen et al., 2003) . W12 cells were cultured on mitomycin-C treated J2 3T3 fibroblast feeder layers in DMEM supplemented with 10% FCS, 2 mM glutamine, 8.4 ng/ml cholera toxin, 0.4 mg/ml hydrocortisone, 10 ng/ml EGF and 1.2 mM Ca 2 þ , as previously (Aasen et al., 2003) .
Episomal maintenance or integration of viral DNA was confirmed by preparation of total genomic DNA and low molecular weight-enriched genomic DNA isolated by the Hirt method (Hirt, 1967) , followed by Southern blotting using a whole HPV16 genome probe.
The U2OS and SAOS2 osteosarcoma cell lines were cultured as previously (Shew et al., 1990) . U2OS expresses wild-type RB, whereas SAOS2 cells only express low levels of a truncated, inactive version of RB (Shew et al., 1990) .
RNA extraction and RT-PCR
RNA extraction and reverse transcription were performed as previously (Larminie et al., 1999) . Primers and cycling parameters have been described for Brf1 (Larminie et al., 1999) , E7 (Li et al., 1998) 7SK: 951C for 3 min, 20 cycles of (951C for 30 s, 571C for 30 s, 721C for 30 s), 721C for 5 min.
Transfection and transcription assays
HeLa cells were transiently transfected using Lipofectamine (Life Technologies Inc.) with pCDNA3HA.BRF1, an expression vector encoding HA-tagged Brf1; they were then synchronized in S phase using a double thymidine block or in early G1 phase after release from a nocodozole block, as previously (White et al., 1995b) , and harvested 72 h post-transfection. Whole-cell extracts were prepared and used for in vitro transcription assays as described (White et al., 1995a) .
